By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Genexine Co. Ltd. 

Seoul      Korea
Phone: 02-785-8950 Fax: 02-785-8957



Company News
Genexine Co. Ltd. Receives Approval To Initiate Phase Ib/II Trial Of GX-188E, HPV Therapeutic DNA Vaccine, In Combination With KEYTRUDA (Pembrolizumab), For The Treatment Of HPV-Induced Cervical Cancer 6/19/2017 8:43:58 AM
Genexine Co. Ltd. Releases Positive Interim Phase II Clinical Data From PGHD Trial With Long-Acting Growth Hormone, GX-H9 At ENDO 2017 4/3/2017 11:20:24 AM
Genexine Co. Ltd. Granted FDA Orphan Drug Designation For GX-H9 In Growth Hormone Deficiency 11/16/2016 8:36:35 AM
Genexine Co. Ltd. Enters Into Clinical Research Collaboration With Merck & Co. (MRK) 11/16/2016 8:34:36 AM
Korea's Genexine Co. Ltd. Forms Clinical Research Collaboration With Merck & Co. (MRK)/MSD 11/11/2016 10:16:48 AM
Korea's Genexine Co. Ltd. Out-licenses Five Molecules to Tasly In $100 Million Deal 10/19/2015 12:52:59 PM
A Co-Development Contract Between Dong-A Pharmaceutical Co., Ltd. and Genexine Co. Ltd. as Win-Win Model to Prepare the International Competition After the FTA Between Korea and USA 6/13/2007 10:05:32 AM